STARGARDT DISEASE 1

Clinical trials for STARGARDT DISEASE 1 explained in plain language.

Never miss a new study

Get alerted when new STARGARDT DISEASE 1 trials appear

Sign up with your email to follow new studies for STARGARDT DISEASE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Completed 1

New drug tested to halt teen vision loss from rare eye disease

Disease control Completed

This study tested whether a drug called tinlarebant could slow the progression of Stargardt disease, a rare genetic condition that causes vision loss in young people. About 104 teenagers and young adults took either the drug or a placebo for up to two years. The main goal was to …

Matched conditions: STARGARDT DISEASE 1

Phase: PHASE3 • Sponsor: Belite Bio, Inc • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

STARGARDT DISEASE 1

Get alerted when new STARGARDT DISEASE 1 trials appear

New drug tested to halt teen vision loss from rare eye disease